Compare COLB & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COLB | CRL |
|---|---|---|
| Founded | 1993 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 8.0B |
| IPO Year | N/A | 2000 |
| Metric | COLB | CRL |
|---|---|---|
| Price | $31.62 | $165.85 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 12 |
| Target Price | $31.18 | ★ $205.27 |
| AVG Volume (30 Days) | ★ 3.0M | 714.2K |
| Earning Date | 01-22-2026 | 02-18-2026 |
| Dividend Yield | ★ 4.62% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.30 | N/A |
| Revenue | $2,151,000,000.00 | ★ $4,023,704,000.00 |
| Revenue This Year | $32.03 | N/A |
| Revenue Next Year | $2.85 | $1.70 |
| P/E Ratio | $13.92 | ★ N/A |
| Revenue Growth | ★ 17.96 | N/A |
| 52 Week Low | $19.61 | $91.86 |
| 52 Week High | $32.70 | $228.88 |
| Indicator | COLB | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 66.23 | 24.23 |
| Support Level | $30.14 | $181.77 |
| Resistance Level | $32.70 | $218.69 |
| Average True Range (ATR) | 0.94 | 8.82 |
| MACD | 0.25 | -5.79 |
| Stochastic Oscillator | 75.20 | 3.36 |
Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.